Results
1 -
10 of
21Population pharmacokinetics of PEGylated liposomal CPT-11 (IHL-305) in patients with advanced solid tumors, European Journal of Clinical Pharmacology Effect of probenecid on the biliary excretion of belotecan, Archives of Pharmacal Research Topoisomerase 1, Cancer Therapeutic Targets Topoisomerase I Inhibitors: Current Use and Prospects, DNA Topoisomerases and Cancer Microdialysis, Handbook of Anticancer Pharmacokinetics and Pharmacodynamics Carrier-Mediated and Targeted Cancer Drug Delivery, Oxidative Stress in Cancer Biology and Therapy In vitro pharmacodynamics of CKD-602 in HT-29 cells, Archives of Pharmacal Research Phase II study of combined belotecan and cisplatin as first-line chemotherapy in patients with extensive disease of small cell lung cancer, Cancer Chemotherapy and Pharmacology A multicenter phase II study of belotecan, a new camptothecin analogue, in elderly patients with previously untreated, extensive-stage small cell lung cancer, Cancer Chemotherapy and Pharmacology Reproductive toxicity evaluation of a new camptothecin anticancer agent, CKD-602, in pregnant/lactating female rats and their offspring, Cancer Chemotherapy and Pharmacology